What smart money is saying about Doximity
1 fund in our archive has pitched Doximity — most recently Liontrust GF Global Innovation Fund in March 2025.
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Get an email when a fund writes about it
Position history
Between Q1 2025 and Q2 2026, 2 fund letters reported a position in Doximity — 2 trimmed or exited.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 2 | 0 | 2 | 0 |
| Q1 2025 | 0 | 0 | 0 | 1 |
Fund activity · 2 positions · 2 moves
- June 2026
“In addition to the transactions mentioned above, we initiated positions in Arxis, Sterling Infrastructure, and Woodward in the industrials sector, SiTime, Cipher Digital, D-Wave Quantum and DigitalOcean in the IT sector, Liftoff Mobile in the communication services sector and Axsome Therapeutics, Vaxcyte and Kymera Therapeutics in the health care sector. We exited positions in FTAI Aviation and Rocket Lab in the industrials sector, Colliers International in the real estate sector, Chime Financial in the financials sector, Doximity in the health care sector and IonQ in the IT sector.”
Doximity - June 2026
“We exited a position in Doximity in the health care sector.”
Doximity
Fund coverage · 1 thesis
- Liontrust GF Global Innovation FundMarch 2025
Doximity is the largest professional network and telehealth platform for healthcare professionals in the US, boasting over 80% of US doctors as verified members, and is well-positioned for strong cash flows and earnings growth despite recent share price declines.
Read the full thesis
Read every full thesis on Doximity
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→